Back to 
ALPS Advisors Inc.
ALPS Advisors Inc.
TNGX
Showing 0 of 3 quarters
Position history for ALPS Advisors Inc.'s holdings in Tango Therapeutics, Inc.
No. ALPS Advisors exited its TNGX (Tango Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 48,071 shares worth $174,000. ALPS Advisors first reported TNGX in Q2 2022 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.